← United States · Coverage record
US · SEC FORM 4
Quanterix Corp
QTRX · Nasdaq · CIK 0001503274 · Healthcare · Medical Devices
INSIDER SIGNAL
2 buyers · 3 purchase transaction lines · $296.0K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Purchase activity is becoming less recent
- ✓ Role scores high · most senior buyer: Chief Commercial Officer
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Chief Commercial Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 58.1
- 58.0
- 57.9
- 57.8
- 57.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- +31.2%
- 3M
- -15.5%
- 6M
- -2.4%
- 12M
- -45.3%
Volatility & liquidity
- Volatility
- 87.2%
- Beta
- —
- Avg daily value
- USD 2.5M
Valuation
- Market cap
- USD 155.1M
- P/E
- —
Fundamentals
- Profit margin
- -77.2%
- ROE
- -36.2%
- Industry
- Medical Devices
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 5,046,958
- Previous report
- 4,976,711
- Avg daily volume
- 679,618
- Days to cover
- 7.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-13 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 72,245 | USD 2.93 | USD 211,678 | SEC filing ↗ |
| 2026-08-12 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 27,155 | USD 2.75 | USD 74,676 | SEC filing ↗ |
| 2026-05-12 | Meadows Benjamin | Purchase (P) | Common Stock | 3,500 | USD 2.77 | USD 9,695 | SEC filing ↗ |
| 2025-09-12 | Sriram Vandana | Purchase (P) | Common Stock | 4,150 | USD 4.79 | USD 19,878 | SEC filing ↗ |
| 2025-06-13 | WALT DAVID R | Purchase (P) | Common Stock | 123,990 | USD 6.14 | USD 761,299 | SEC filing ↗ |
| 2025-06-12 | WALT DAVID R | Purchase (P) | Common Stock | 36,010 | USD 6.23 | USD 224,342 | SEC filing ↗ |
| 2025-06-09 | Toloue Masoud | Purchase (P) | Common Stock | 45,900 | USD 5.42 | USD 248,778 | SEC filing ↗ |
| 2025-06-09 | WALT DAVID R | Purchase (P) | Common Stock | 78,131 | USD 5.34 | USD 417,220 | SEC filing ↗ |
| 2025-06-06 | WALT DAVID R | Purchase (P) | Common Stock | 131,869 | USD 5.43 | USD 716,049 | SEC filing ↗ |
| 2025-06-06 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 93,113 | USD 5.44 | USD 506,535 | SEC filing ↗ |
| 2024-08-20 | WALT DAVID R | Purchase (P) | Common Stock | 47,000 | USD 13.29 | USD 624,630 | SEC filing ↗ |
| 2024-08-13 | Toloue Masoud | Purchase (P) | Common Stock | 19,000 | USD 10.90 | USD 207,100 | SEC filing ↗ |
| 2023-09-08 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 20,200 | USD 24.85 | USD 501,970 | SEC filing ↗ |
| 2022-08-15 | DOYLE MICHAEL A | Purchase (P) | Common Stock | 15,000 | USD 10.16 | USD 152,400 | SEC filing ↗ |
| 2022-08-12 | Toloue Masoud | Purchase (P) | Common Stock | 105,000 | USD 10.43 | USD 1,095,150 | SEC filing ↗ |
Form 4 evidence
148 transaction lines in the latest 365-day window; 996 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-10-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 3.07 | USD 1,308 | SEC filing ↗ |
| 2026-10-02 | Magovcevic-Liebisch Ivana | Option exercise / conversion (M) | Common Stock | 4,224 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-10-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 3.07 | USD 1,308 | SEC filing ↗ |
| 2026-10-02 | Magovcevic-Liebisch Ivana | Option exercise / conversion (M) | Common Stock | 4,224 | USD — | USD — | SEC filing ↗ |
| 2026-10-01 | Mendel Scott | Award / grant (A) | Common Stock | 4,398 | USD 3.41 | USD 14,997 | SEC filing ↗ |
| 2026-10-01 | DONNELLY WILLIAM P | Award / grant (A) | Common Stock | 6,964 | USD 3.41 | USD 23,747 | SEC filing ↗ |
| 2026-09-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-09-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 2.72 | USD 1,159 | SEC filing ↗ |
| 2026-08-31 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 159 | USD — | USD — | SEC filing ↗ |
| 2026-08-31 | Miller Michael Francis | Tax withholding (F) | Common Stock | 48 | USD 2.67 | USD 128 | SEC filing ↗ |
| 2026-08-19 | Elliott Jeffrey Thomas | Option exercise / conversion (M) | Common Stock | 3,955 | USD — | USD — | SEC filing ↗ |
| 2026-08-17 | DONNELLY WILLIAM P | Option exercise / conversion (M) | Common Stock | 2,802 | USD — | USD — | SEC filing ↗ |
| 2026-08-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-08-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 2.59 | USD 1,103 | SEC filing ↗ |
| 2026-08-13 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 72,245 | USD 2.93 | USD 211,678 | SEC filing ↗ |
| 2026-08-12 | DONNELLY WILLIAM P | Purchase (P) | Common Stock | 27,155 | USD 2.75 | USD 74,676 | SEC filing ↗ |
| 2026-07-31 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 130 | USD — | USD — | SEC filing ↗ |
| 2026-07-31 | Miller Michael Francis | Tax withholding (F) | Common Stock | 39 | USD 3.48 | USD 136 | SEC filing ↗ |
| 2026-07-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 4.24 | USD 1,806 | SEC filing ↗ |
| 2026-07-08 | Mendel Scott | Option exercise / conversion (M) | Common Stock | 8,073 | USD — | USD — | SEC filing ↗ |
| 2026-07-08 | LAI GOLDMAN MYLA | Option exercise / conversion (M) | Common Stock | 8,073 | USD — | USD — | SEC filing ↗ |
| 2026-07-01 | Mendel Scott | Award / grant (A) | Common Stock | 3,456 | USD 4.34 | USD 14,999 | SEC filing ↗ |
| 2026-07-01 | DONNELLY WILLIAM P | Award / grant (A) | Common Stock | 5,472 | USD 4.34 | USD 23,748 | SEC filing ↗ |
| 2026-06-30 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 130 | USD — | USD — | SEC filing ↗ |
| 2026-06-30 | Miller Michael Francis | Tax withholding (F) | Common Stock | 39 | USD 4.32 | USD 168 | SEC filing ↗ |
| 2026-06-15 | Sriram Vandana | Option exercise / conversion (M) | Common Stock | 1,833 | USD — | USD — | SEC filing ↗ |
| 2026-06-15 | Sriram Vandana | Tax withholding (F) | Common Stock | 548 | USD 3.10 | USD 1,699 | SEC filing ↗ |
| 2026-06-15 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 1,558 | USD — | USD — | SEC filing ↗ |
| 2026-06-15 | Miller Michael Francis | Tax withholding (F) | Common Stock | 426 | USD 3.10 | USD 1,321 | SEC filing ↗ |
| 2026-05-31 | Miller Michael Francis | Option exercise / conversion (M) | Common Stock | 130 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | QTRX |
| CIK | 0001503274 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 996 transaction lines from 2020-01-02 to 2026-10-15 23 P purchase lines · 462 S sale lines · 511 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.